04/29/2024 6:28 PM | ARCA biopharma (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
04/25/2024 3:27 PM | ARCA biopharma (Subject)
| Form 425 | |
04/23/2024 3:20 PM | ARCA biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/15/2024 4:29 PM | Allostery Investments LP (Filed by) ARCA biopharma (Subject)
| Form SC 13G | |
04/11/2024 8:51 AM | ARCA biopharma (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
04/09/2024 7:57 PM | ARCA biopharma (Subject) Avidity Partners Management LP (Filed by)
| Form SC 13G | |
04/05/2024 6:38 PM | ARCA biopharma (Subject) Western Standard LLC (Filed by)
| Form SC 13G/A | |
04/03/2024 6:31 AM | ARCA biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/03/2024 6:33 AM | ARCA biopharma (Subject)
| Form 425 | |
02/07/2024 12:08 PM | ARCA biopharma (Subject) BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/01/2024 3:39 PM | ARCA biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/31/2024 5:39 PM | ARCA biopharma (Issuer) Ma-Weaver Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:25 PM | ARCA biopharma (Issuer) Woosley Raymond L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:25 PM | ARCA biopharma (Issuer) Grais Linda (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:25 PM | ARCA biopharma (Issuer) CONWAY ROBERT E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:25 PM | ARCA biopharma (Issuer) Flynn James P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:25 PM | ARCA biopharma (Issuer) MITCHELL DANIEL J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:25 PM | ARCA biopharma (Issuer) Hove Anders D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:25 PM | ARCA biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/04/2023 3:36 PM | ARCA biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2023 3:15 PM | ARCA biopharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/18/2023 3:35 PM | ARCA biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/21/2023 3:35 PM | ARCA biopharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/21/2023 3:16 PM | ARCA biopharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |